Prostaglandin-D-synthase levels in cerebrospinal fluid associated with altered tau proteins in patients with suspected Alzheimer's disease

被引：0
|
作者：
Morell-Garcia, D. [2 ]
Ballesteros-Vizoso, M. A. [1 ]
Bauca, J. M. [2 ]
Garcia-Martin, A. [3 ]
Tarongi, S. [3 ]
Amer, G. [3 ]
Barcelo, A. [2 ]
机构：
[1] Hlth Res Inst Balearic Isl, Palma de Mallorca, Spain
[2] Son Espases Univ Hosp, Lab Med Dept, Palma de Mallorca, Spain
[3] Son Espases Univ Hosp, Neurol Dept, Palma de Mallorca, Spain
来源：
CLINICA CHIMICA ACTA | 2022年 / 530卷
关键词：
D O I：
10.1016/j.cca.2022.04.908
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
W157
引用
收藏
页码：S352 / S352
页数：1
相关论文
共 50 条
  • [1] Prostaglandin-D-synthase (β-trace protein) levels in rat cerebrospinal fluid
    Kabeya, K
    Ishikawa, K
    Katakai, K
    Watanabe, M
    Ohe, Y
    Wakabayashi, K
    Mori, M
    NEUROREPORT, 1998, 9 (05) : 915 - 919
  • [2] DAYTIME SLEEPINESS IS ASSOCIATED WITH INCREASED CEREBROSPINAL FLUID TAU PROTEINS IN ALZHEIMER'S DISEASE
    Okamoto, Cynthia
    Sordo, Lorena
    Neikrug, Ariel
    Grill, Joshua
    Head, Elizabeth
    Benca, Ruth
    Sultzer, David
    Mander, Bryce
    SLEEP, 2024, 47
  • [3] Tau proteins in cerebrospinal fluid from patients with Alzheimer's disease: A longitudinal study
    Isoe, K
    Urakami, K
    Shimomura, T
    Wakutani, Y
    Ji, Y
    Adachi, Y
    Takahashi, K
    DEMENTIA, 1996, 7 (03): : 175 - 176
  • [4] Tau phosphorylation pathway genes and cerebrospinal fluid tau levels in Alzheimer's disease
    Bekris, Lynn M.
    Millard, Steve
    Lutz, Franziska
    Li, Gail
    Galasko, Doug R.
    Farlow, Martin R.
    Quinn, Joseph F.
    Kaye, Jeffrey A.
    Leverenz, James B.
    Tsuang, Debby W.
    Yu, Chang-En
    Peskind, Elaine R.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2012, 159B (07) : 874 - 883
  • [5] Increased Cerebrospinal Fluid Tau Levels in Logopenic Variant of Alzheimer's Disease
    Magnin, Eloi
    Paquet, Claire
    Formaglio, Maite
    Croisile, Bernard
    Chamard, Ludivine
    Miguet-Alfonsi, Carole
    Tio, Gregory
    Dumurgier, Julien
    Roullet-Solignac, Isabelle
    Sauvee, Mathilde
    Thomas-Anterion, Catherine
    Vighetto, Alain
    Hugon, Jacques
    Vandel, Pierre
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 39 (03) : 611 - 616
  • [6] Cerebrospinal fluid levels of Aβ42 and tau:: potential markers of Alzheimer's disease
    Galasko, D
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1998, (53): : 209 - 221
  • [7] FOLLOW-UP STUDY ON PLASMA AND CEREBROSPINAL FLUID LEVELS OF B AMYLOIDS AND TAU PROTEINS IN PATIENTS WITH ALZHEIMER'S DISEASE
    Fu, Y.
    Xiao, S.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [8] Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
    Pieter Jelle Visser
    Lianne M. Reus
    Johan Gobom
    Iris Jansen
    Ellen Dicks
    Sven J. van der Lee
    Magda Tsolaki
    Frans R. J. Verhey
    Julius Popp
    Pablo Martinez-Lage
    Rik Vandenberghe
    Alberto Lleó
    José Luís Molinuevo
    Sebastiaan Engelborghs
    Yvonne Freund-Levi
    Lutz Froelich
    Kristel Sleegers
    Valerija Dobricic
    Simon Lovestone
    Johannes Streffer
    Stephanie J. B. Vos
    Isabelle Bos
    August B. Smit
    Kaj Blennow
    Philip Scheltens
    Charlotte E. Teunissen
    Lars Bertram
    Henrik Zetterberg
    Betty M. Tijms
    Molecular Neurodegeneration, 17
  • [9] Cerebrospinal fluid β-amyloid and tau proteins for the diagnosis of Alzheimer disease
    Knopman, D
    ARCHIVES OF NEUROLOGY, 2001, 58 (03) : 349 - 350
  • [10] Altered TIMP-3 Levels in the Cerebrospinal Fluid and Plasma of Patients with Alzheimer's Disease
    Park, Jung Hyun
    Cho, Sun-Jung
    Jo, Chulman
    Park, Moon Ho
    Han, Changsu
    Kim, Eun-Joo
    Huh, Gi Yeong
    Koh, Young Ho
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (05):
12345